Donald P. Lehr
Known title: Chief Legal OfficerCIK: 0001583187
Associated companies
Transaction History
| PGEN | ▼ Sell | Tax Withholding | 2,488 | $18K | 8/23/2026 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 5,208 | — | 8/23/2026 | View on chart |
| PGEN | ▼ Sell | Open Market | 29,131 | $127K | 5/28/2026 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 62,500 | — | 5/23/2026 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 40,443 | — | 3/18/2026 | View on chart |
| PGEN | ▼ Sell | Tax Withholding | 55,101 | $80K | 5/16/2025 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 165,468 | — | 5/16/2025 | View on chart |
| PGEN | ▲ Buy | Grant | 54,000 | $0 | 1/29/2025 | View on chart |
| PGEN | ▼ Sell | Tax Withholding | 20,844 | $27K | 1/29/2025 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 164,285 | — | 4/5/2024 | View on chart |
| PGEN | ▼ Sell | Tax Withholding | 55,075 | $77K | 4/5/2024 | View on chart |
| PGEN | ▼ Sell | Open Market | 10,947 | $18K | 8/24/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 21,710 | — | 8/23/2023 | View on chart |
| PGEN | ▼ Sell | Open Market | 10,762 | $17K | 8/17/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 21,710 | — | 8/16/2023 | View on chart |
| PGEN | ▼ Sell | Open Market | 11,026 | $13K | 8/10/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 21,710 | — | 8/9/2023 | View on chart |
| PGEN | ▼ Sell | Open Market | 10,821 | $13K | 8/3/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 21,710 | — | 8/2/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 43,419 | — | 3/24/2023 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 18,939 | — | 1/4/2023 | View on chart |
| PGEN | ▼ Sell | Open Market | 18,196 | $23K | 5/17/2022 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 36,590 | — | 5/16/2022 | View on chart |
| PGEN | ▼ Sell | Open Market | 10,356 | $37K | 1/5/2022 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 18,939 | — | 1/4/2022 | View on chart |
| PGEN | ▼ Sell | Open Market | 5,315 | $20K | 1/3/2022 | View on chart |
| PGEN | ▲ Buy | Option Exercise | 9,765 | — | 1/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Precigen mentioned in Zacks analyst blog
Precigen was highlighted in a Zacks analyst blog alongside other companies. The stock has risen more than 50% over the last three months, moving within its 52-week range of $2.99 to $8.98. Analysts currently have an average price target of $13.65 for the shares.
Precigen mentioned in Zacks analyst blog. Precigen was highlighted in a Zacks analyst blog alongside other companies. The stock has risen more than 50% over the last three months, moving within its 52-week range of $2.99 to $8.98. Analysts currently have an average price target of $13.65 for the shares.